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Abstract
Background: Invasive electrode monitoring provides more 
precise localization of epileptogenic foci in patients with 
medically refractory epilepsy. The use of hybrid depth elec-
trodes that include microwires for simultaneous single-neu-
ron monitoring is becoming more widespread. Objective: To 
determine the safety and utility of hybrid depth electrodes 
for intracranial monitoring of medically refractory epilepsy. 
Methods: We reviewed the medical charts of 53 cases of 
medically refractory epilepsy operated on from 2006 to 
2017, where both non-hybrid and hybrid microwire depth 
electrodes were used for intracranial monitoring. We as-
sessed the localization accuracy and complications that 
arose to assess the relative safety and utility of hybrid depth 
electrodes compared with standard electrodes. Results: A 
total of 555 electrodes were implanted in 52 patients. The 
overall per-electrode complication rate was 2.3%, with a per-
case complication rate of 20.8%. There were no infections or 
deaths. Serious or hemorrhagic complications occurred in 2 
patients (0.4% per-electrode risk). Complications did not cor-
relate with the use of any particular electrode type, and hy-
brids were equally as reliable as standard electrodes in local-
izing seizure onset zones. Conclusions: Hybrid depth elec-
trodes appear to be as safe and effective as standard depth 
electrodes for intracranial monitoring and provide unique 
opportunities to study the human brain at single-neuron res-
olution. © 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Invasive monitoring remains a cornerstone in the di-
agnostic workup of patients with medically refractory ep-
ilepsy. Invasive monitoring using depth electrodes offers 
an opportunity to localize seizure onset zones in deeper 
structures such as the hippocampus, the amygdala or the 
insula, when they cannot be localized accurately with 
scalp electroencephalography (EEG) or other noninva-
sive methods. This technique, also referred to as stereo-
EEG (SEEG), provides more anatomically precise ways to 
evaluate seizure network spread patterns [1]. However, 
the multiple brain penetrations associated with depth 
electrodes pose certain risks, such as intracerebral bleed-
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
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ing, infection, and cortical damage. Several reports docu-
ment the benefits and risks of depth electrodes relative to 
subdural grid and strip monitoring. These reports dem-
onstrate that, relative to grids and strips, depth electrodes 
are associated with lower complication rates, and better 
outcomes have been reported 1 year after resective sur-
gery [2–7]. Thus, there is considerable justification to uti-
lize depth electrodes instead of grids when clinically war-
ranted.
A secondary benefit of depth electrode monitoring is 
that it permits the study of single-neuron activity during 
both normal behavior and ictal and interictal events [8]. 
For these applications, “hybrid” depth electrodes are used 
that contain additional microwire bundles that exit from 
the tip of the clinical macro-contact electrode (Fig. 1a). 
This modification provides a tremendous opportunity to 
study the human nervous system at a single-cell resolu-
tion in awake, behaving humans [8]. This setup has led to 
key new insights into the mechanisms of cognition, in-
cluding long-term and working memory [9, 10], high-
level visual representations [11–13], face processing and 
its impairment in autism [14, 15], processing of emotions 
[16, 17], and decision making [18]. To date, only one 
study has documented that the addition of microwires 
did not increase the risks of implantation [19]. However, 
when compared to standard depth electrodes, there is still 
a paucity of information on the safety and risks associated 
with hybrid depth electrodes. To address this concern, we 
performed a single-center retrospective analysis of our 
most recent 10-year case series with hybrid depth elec-
trodes, seeking to compare the safety profile and ability of 
hybrid electrodes to localize seizures with well-reported 
results for non-hybrid electrodes.
Methods
Data Extraction
The personal surgical database of a single surgeon (A.N.M.) 
was reviewed to identify all patients with medically refractory epi-
lepsy who underwent stereotactic depth electrode insertion proce-
dures between 2006 and 2017. The medical chart for each patient 
was reviewed to extract the following information: patient demo-
graphics (age, gender, race), duration of epilepsy until time of im-
plant, indication for depth electrode monitoring, number and sites 
of electrodes implanted, types of electrode implanted, and final 
localization of seizures (if localized). Records were also reviewed 
to determine the length of implantation and any complications 
related to the implant procedure, recording period, or explant and 
postoperative course. The study was approved by the Institutional 
Review Boards of all participating hospitals.
Surgical Technique 
The surgical methods employed remained essentially un-
changed over the entire study period and are described in detail 
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a
Fig. 1. a Schematic of a hybrid macro-micro depth electrode. b Postoperative plain skull X-ray (left panel) and 
MRI (middle and right panels) illustrating depth electrode placement.
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elsewhere [20]. Patients underwent a preoperative 1.5- or 3-T MRI 
of the entire brain with and without contrast, including SPGR (or 
equivalent) sequences in the axial and coronal planes. A CT angio-
gram with the stereotactic frame in place was acquired on the 
morning of surgery, and co-registered to the MRI during electrode 
targeting planning, which was performed on the same day as sur-
gery. Both the CTA and MRI with contrast were used to avoid tra-
versing sulci, and to identify surface arteries and veins, deeper ves-
sels, and anatomic targets. Electrode targeting was planned with 
the Framelink® (Medtronic, Minneapolis, MN, USA) stereotactic 
software suite. Implantations were performed using a CRW (In-
tegra, Plainsboro, NJ, USA) stereotactic frame with a custom-
made Cosgrove Depth Electrode Insertion Kit (AdTech Medical, 
Racine, WI, USA). This resulted in orthogonal electrode place-
ments (Fig. 1b), which were used for the great majority of electrode 
insertions. For nonorthogonal placements, the standard CRW arc 
was used.
Patients were implanted either under deep sedation with pro-
pofol or under general anesthesia (laryngeal mask). There were no 
anesthetic complications. For orthogonal targets, a standard tar-
geting method was utilized as described in detail elsewhere [20]. 
The three types of electrodes used in this series were standard 
1.1-mm-diameter non-hybrid depth electrodes (Spencer® SD08R-
SP05X-000; Ad-Tech Medical, Racine, WI, USA), 1.3-mm-diam-
eter hybrid depth electrodes [21] with associated internal microw-
ires (Behnke-Fried BF08R-SP05X-000 and WB09R-SP00X-0B6; 
Ad-Tech Medical) [20] (Fig. 1a), and 0.8-mm-diameter non-hy-
brid Spencer® SEEG electrodes (RD06R-SP05X-000; Ad-Tech 
Medical). When hybrid Behnke-Fried electrodes were used, the 
macroelectrode was first inserted to target, and the microbundle 
was then passed through the hollow core of the macrobundle so 
that it protruded 4–6 mm from the end of the macroelectrode, af-
ter which the anchor bolt cap was tightened to hold the electrode 
assembly in place. Typically, we placed electrodes in bilateral sym-
metric mesial temporal and mesial frontal targets, with supple-
mentary and nonorthogonal electrodes when clinically indicated. 
We obtained formal anteroposterior, lateral, and submental vertex 
plain skull films as well as postoperative MRI without contrast on 
all patients to determine final electrode placements (Fig. 1b).
Patients received intravenous cefazolin for 48 h after surgery. 
Antiepileptic drugs were tapered as indicated, and dressing chang-
es were also performed typically once per week. When monitoring 
was complete the electrodes were removed in the operating room 
under sedation. Patients typically left the hospital the next morn-
ing.
Results
Complete data were available for a total of 52 patients, 
42 from Hospital 1 and 10 from Hospital 2, who under-
went a total of 53 stereotactic placement of depth elec-
trodes surgeries. Patient demographics are listed in Table 
1. Briefly, there were 26 males and 26 females, with an 
average age at implant of 37 ± 14.1 years (range 16–70 
years). The mean length of time with medically refractory 
epilepsy prior to depth electrode monitoring was 18 ± 
15.2 years (range 1–53 years). Patient ethnicity could only 
be retrieved for Hospital 1 patients due to limited access 
to full demographic data at Hospital 2. Of the 42 Hospital 
1 patients, 38.1% were Caucasian, 11.9% African Ameri-
can, 9.5% Asian, 33.3% Hispanic, and 7.2% other. As both 
hospitals were in similar catchment areas, demographics 
were likely very similar between the two centers.
Hospital Stay
The average time spent for continuous video EEG ep-
ilepsy monitoring was 15 ± 7.0 days, with an average hos-
pital stay of 16 ± 6.8 days. The number of electrodes in 
each site over the entire patient population is listed in 
Table 2. The majority of patients underwent bilateral im-
plant with electrodes targeting the mesial temporal areas 
(amygdala, hippocampus) and frontal (orbitofrontal gy-
rus, pre-supplementary motor area, anterior cingulate 
cortex) lobes. These areas were determined by clinical cri-
teria alone. No electrodes were placed solely for research 
purposes. In some cases, electrodes were inserted in non-
standard target areas; typical indications for these elec-
trode placements were suspected structural lesions (e.g., 
focal cortical dysplasia or tumor), or noninvasive moni-
toring suggesting potential involvement of that region. A 
total of 555 electrodes were implanted over the 11-year 
period reviewed (Table 2). On average, each patient had 
10 electrodes. Of the 555 electrodes, 244 (44%) standard 
depth electrodes (Spencer®), 288 (52%) hybrid (Behnke-
Table 1. Population demographics and data
Population data Total
Patients 52
Male
Female
26 (50.0)
26 (50.0)
Hospital
Hospital 1
Hospital 2
42 (80.8)
10 (19.2)
Age, years 37±14.1
Length of time with epilepsy, years 18±15.2
Length of time with implants, days 15±7.0
Ethnicity1
Caucasian
African American 
Asian
Hispanic
Other
16 (38.1)
5 (11.9)
4 (9.5)
14 (33.3)
3 (7.2)
Values are n (%) or mean ± SD, as appropriate. 1 Hospital 1 pa-
tients only.
Carlson/Rutishauser/MamelakStereotact Funct Neurosurg 2018;96:311–319314
DOI: 10.1159/000493548
Fried) electrodes with associated internal microwires 
(Fig. 1a), and 23 (4%) smaller-diameter non-hybrid SEEG 
electrodes were implanted (Table 2). Of 53 cases, 43 
(81.1%) included hybrid depth electrodes, with an aver-
age of 5 ± 3 hybrid depth electrodes used per case. As the 
hybrid electrodes were primarily used for research pur-
poses, they were only implanted in the areas relevant to 
our research objectives. However, over time and as our 
studies expanded, hybrid electrodes replaced non-hybrid 
ones in many areas. For example, in cases early in our se-
ries hybrid electrodes were implanted solely in the amyg-
dala and hippocampus, while for later cases (after 2009) 
hybrid electrodes were also implanted in the frontal lobe 
targets. SEEG electrodes were used in later (after 2014) 
cases, targeting the insula and parieto-occipital regions 
when indicated by noninvasive data. 
Surgical Outcome 
The reason for depth electrode implantation was local-
ization of epileptic foci. We therefore first categorized lo-
calization efficacy into three categories: not localized, 
partially localized, and localized. Poor localization oc-
curred if the characteristics of the seizures captured sug-
gested no clear epileptic focal point, there was a lack of 
seizure activity during monitoring, onset appeared not to 
arise from any of the contacts, or monitoring was ended 
prior to clear localization due to patient safety concerns. 
Partially localized seizures include those that were identi-
fied as possibly neocortical, but subdural grids were sub-
sequently needed to further localize. Alternatively, areas 
of involvement were identified, but no clear localization 
of onset could be determined, thus further localization 
procedures were needed. Localized patients demonstrat-
ed stereotypical and reproducible seizure onset patterns, 
or multifocal independent onsets that no longer made the 
patient a resective surgery candidate. Of the 52 patients 
(53 cases), 32 (61.5%) had their epilepsy localized, 10 
(19.2%) had their epilepsy partially localized, and 10 
(19.2%) did not have localization. 
To compare the seizure-localizing capabilities of non-
hybrid versus hybrid electrodes, we analyzed the localiza-
tion outcome in patients who were implanted with at least 
4 hybrid electrodes (as this was the minimum number of 
hybrid electrodes used in all cases involving hybrid elec-
trodes) and compared it to patients who only had non-
hybrid electrodes implanted. We found that the probabil-
ity of epilepsy localization was not different between the 
two groups (p = 1, Fisher exact test 2 × 2 contingency 
table). When restricting the localization criterion even 
further to localized, partially localized, or not localized, 
we found that 72.5% of patients who had hybrid elec-
trodes implanted had their seizures localized, 15.0% had 
Table 2. Electrode medial target locations and number of each electrode type per area
Brain area Electrodes Standard 
electrodes
Hybrid 
electrodes
SEEG 
electrodes
Amygdala
Hippocampus
Anterior cingulate gyrus
Supplementary motor area
Orbital frontal cortex
Other
103
104
104
104
104
36
17
18
38
68
90
13
86
86
66
36
14
0
0
0
0
0
0
23
Total electrodes 555 244 (44%) 288 (52%) 23 (4%)
Not localized
Pa
tie
nt
s, 
%
Partially localized
Extent of localization of seizure onset zone
Localized
80 ■ Hybrid electrodes implanted
■ Only non-hybrid electrodes implanted70
60
50
40
30
20
10
0
Fig. 2. Localization outcome comparison between patients who 
had at least 4 hybrid electrodes implanted and patients who only 
had non-hybrid electrodes implanted. All differences between 
groups were not statistically significant.
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them partially localized, and 12.5% had their seizures not 
localized (Fig. 2). In patients with only non-hybrid elec-
trodes implanted, 44.4% of patients had their seizures lo-
calized, 44.4% had them partially localized, and 11.1% 
had their seizures not localized (Fig. 2). Like our previous 
comparison, we found that there was no statistical differ-
ence in the probability of having seizures localized, par-
tially localized, or not localized between patients who had 
at least 4 hybrid electrodes implanted and patients with 
only non-hybrid electrodes used for monitoring (p = 0.15, 
Fisher exact test 2 × 3 contingency table). Patients who 
were categorized as not localized due to lack of seizure 
activity during monitoring, or monitoring was ended pri-
or to clear localization due to patient safety concerns, 
were not included in these comparisons.
After depth electrode monitoring and any additional 
diagnostic tests were completed, common procedures 
that followed were resective surgery or MRI-guided laser 
ablation (Visualase®; Medtronic) if localization was de-
termined, subdural grid placement for further localiza-
tion, vagal nerve stimulator (Cyberonics Inc., Houston, 
TX, USA) implantation for patients with nonlocalized 
epilepsy, responsive neural stimulation (NeuroPace®, 
Mountain View, CA, USA) implant, or in some cases, no 
further surgical treatment (Table 3).
Complications
Of 53 procedures and 555 depth electrode insertions, 
operative or postoperative complications were noted in 
11 (20.8%) procedures. This translated to an overall per-
electrode complication rate of 2.3%. We quantified each 
type of complication observed on a per-electrode basis 
(Table 4). For 7 electrodes (1.3%), complications arose 
from difficulties involving bolt or electrode insertion or 
removal procedures. For example, during the insertion 
procedure, part of an anchor bolt fractured and was left 
in place in the skull or later removed during electrode re-
moval. In one instance, a hybrid electrode sheared off 
during removal and was later removed during the sched-
uled resection surgery. It is important to note that hard-
ware breakages, which did not result in brain damage or 
were otherwise clinically insignificant, made up most of 
our complication rate and when removed our complica-
tion rates were 11.3% per case and 1.1% per electrode. 
There were no instances of electrode-related infection, ei-
ther during implantation and continuous EEG monitor-
ing, or after removal. 
We documented 6 occurrences of postoperative bleed-
ing from either an electrode insertion or removal (1.1%) 
in 5 patients. Of these 6 occurrences, 4 involved small or 
asymptomatic bleeds that did not have a neurological 
consequence and no surgical intervention was needed. 
These included 1 patient noted to have a small subarach-
noid bleed and a small subdural hematoma (Fig. 3a) after 
electrode removal, 1 patient with a small left intraven-
tricular bleed (Fig. 3b), and 1 patient with diffuse sub-
arachnoid bleed after implantation (Fig. 3c), without clin-
ical sequalae or underlying vascular lesion identified by 
MR angiogram. All 3 patients were asymptomatic from 
these episodes, with blood detected on routine postsurgi-
cal imaging. Postoperative bleeding that required surgical 
intervention occurred in 2 cases (0.4%). One patient 
(Fig. 3d), was noted to have left-sided hemiparesis and a 
dilated right pupil in the recovery room 30 min after re-
moval of depth electrodes. A CT revealed an acute right 
subdural hematoma, which was urgently evacuated via 
craniotomy with full recovery. At surgery to remove the 
hematoma no clear source of bleeding was identified. The 
patient made a rapid recovery and subsequently under-
went temporal lobectomy 6 weeks later. A second patient 
(Fig. 3e, f) developed a left anterior temporal intraparen-
chymal hematoma that was identified shortly after im-
plantation, while still in the recovery room. The patient 
became acutely aphasic and somnolent and underwent 
emergency removal of the electrodes and evacuation of 
Table 3. Subsequent treatment of patients following depth elec-
trodes
Type of procedure Patients, n
Resection/ablation
Subdural grid and resection 
Vagal nerve stimulator
No further surgical treatment
25
8
5
15
Table 4. Complications on a per-patient basis and per-electrode 
basis
Type of complication Patients, 
n (%)
Electrodes, 
n (%)
Anchor bolt or electrode break
Bleeding 
Bleeding requiring surgery
Infarction/stroke
6 (11.5)
5 (9.6)
2 (3.8)
1 (1.9)
7 (1.3)
6 (1.1)
2 (0.4)
0 (0.0)1
1  Complication not directly associated with depth electrode 
insertion or removal.
Carlson/Rutishauser/MamelakStereotact Funct Neurosurg 2018;96:311–319316
DOI: 10.1159/000493548
the hematoma. At surgery active bleeding from a small 
artery in the anterior temporal lobe was identified as the 
suspected source of bleeding, although it was not clear if 
this was caused by a hybrid electrode or an SEEG elec-
trode, both placed within 1 cm of each other. The pa-
tient’s aphasia progressively improved almost back to 
normal by 4 months after surgery, and she has remained 
seizure free. One patient developed a small lacunar left 
thalamic infarction with residual sensory deficit after de-
plantation. As none of the electrodes were near the site of 
infarct, this was suspected to be related to the patient’s 
history of thrombophilia rather than electrode insertion 
or removal and thus did not contribute to our overall per-
electrode complication rate. 
We compared cases in which 4 or more hybrid elec-
trodes were used (“hybrid cases”) to cases where no hy-
brid electrodes were used (“standard cases”). When com-
paring the per-electrode complication rates between hy-
brid and standard electrode cases, we found that 2 (0.7%) 
complications occurred with standard electrode cases 
and 5 (1.7%) complications occurred with hybrid cases 
This difference was not statistically significant. This ex-
cludes any complications specifically involving bolt in-
sertion and removal as these do not depend on electrode 
type, and the same bolt was used for both electrode types 
(except for SEEG electrodes for which 1 bolt-related com-
plication was reported). Additionally, when looking at 
the specific characteristics of each complication such as 
location of bleed and what vascular structures were iden-
tified as the source of bleeding, we determined that no 
complications could be directly or indirectly attributed to 
the use of hybrid electrodes. More specifically, the 2 clin-
ically significant bleeds did not occur near the site of the 
microwires, and the 4 instances of nonclinically signifi-
cant bleeds did not occur proximal enough to the mi-
crowire locations to be directly attributed to the hybrid 
electrodes. Since the microwire bundle is inserted only 
after the main macroelectrode is inserted, only bleeds that 
a b c
d e f
Fig. 3. Hemorrhagic complications. a Small right subdural and left subarachnoid bleed. b Small left intraven-
tricular blood (ellipse). c Diffuse subarachnoid bleed. Hemorrhages shown in a–c were clinically asymptomatic. 
d Large subdural hematoma that developed after electrode removal. e, f Large left intraparenchymal hemorrhage 
that developed immediately after implant. Note the upward displacement of the left temporal electrodes on the 
postoperative skull film corresponding to the temporal hematoma seen on CT. Patients in d–f required surgical 
evacuation of hematoma.
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occurred at the most medial aspect of the electrode would 
be directly related to the microwires, and no bleed of that 
sort was identified.
Utility of Hybrid Electrodes for Single Unit 
Recording
The yield of extracellular single-neuron action poten-
tials recorded from the hybrid microwires was variable 
and improved over time as techniques and equipment 
improved. Early in our experience single-unit data could 
be collected from an average of 3–4 (37%) microwire 
bundles, while later single units were typically achieved in 
70–80% of microwires. Units could reliably be recorded 
for over 2 weeks. An average of 3–7 isolated single units 
could be obtained from each microwire, with extreme 
variability ranging from 0–16 units per bundle. The 
amygdala tended to yield the most reliable recordings, 
followed by the anterior cingulate cortex, pre-supple-
mentary motor area, and hippocampus. High-quality lo-
cal field potentials could be recorded from microwires in 
essentially every bundle unless the entire bundle had high 
impedances, which occurred in < 5% of all electrodes im-
planted. 
Discussion
To effectively manage medically refractory epilepsy, 
precise localization of the epileptogenic zone is crucial. 
Invasive electrode monitoring provides an opportunity to 
more accurately localize the zone of seizure onset, espe-
cially in cases of nonlesional epilepsy. Depth electrodes 
offer distinct advantages in these settings, allowing for 
monitoring of medial structures, white matter, and lat-
eral cortical structure simultaneously. Several series have 
documented that depth electrode monitoring is both safe 
and effective, with overall per-case complication rates 
ranging from 1 to 26% [2–6, 19, 22, 23]. Our series reports 
similar results, with an overall per-case complication rate 
of 20.8% and a per-electrode rate of 2.3%. The majority of 
our reported complications were minor and related to 
hardware breakage. This may suggest an error in surgical 
technique and indeed we are now very careful when tight-
ening in the anchor bolts to avoid shearing loads. No in-
stances of anchor bolt breakage have been noted in the 
past 18 months. 
Overall hemorrhagic complications were extremely 
low, at 0.4% per electrode. Only 2 out of 52 patients re-
quired surgical intervention. None of the complications 
that occurred could be directly attributed to the use of 
hybrid electrodes containing microwires. Further, it 
seems improbable that the 0.2-mm difference in diameter 
between the hybrid (1.3 mm) and standard (1.1 mm) elec-
trodes would result in a meaningful change in hemor-
rhage rate, a finding supported by our data.
Our reported hemorrhage rate with hybrid electrodes 
was slightly higher (1.7%) than that with standard elec-
trodes (0.7%). This difference was not statistically signif-
icant. As we implanted more hybrid electrodes (52%) 
than standard (44%) or SEEG electrodes (4%), we might 
expect to see a slightly higher bleeding rate with hybrids. 
If we assume the risk for bleeding is identical for all elec-
trode types, we would theoretically have expected to see a 
1.0% bleed rate with standard electrodes, a 1.2% rate with 
hybrids, and a 0.1% rate for SEEG electrodes. These re-
sults closely approximate our findings and suggest that 
there does not appear to be any difference in complica-
tion rate between standard and hybrid electrodes. 
Of note, since we used identical anchor bolts for our 
standard and hybrid electrodes, and hardware breakage 
represented our most common complication, it is possi-
ble that there would be a reduction in complications if 
only SEEG anchor bolts, which are smaller, were used. 
However, as only 4% of our electrodes were SEEG we 
have insufficient data to support his view. A larger, mul-
ticenter database incorporating significantly large num-
bers of patients with both SEEG and hybrid electrodes is 
needed to more definitively answer this question. 
Some studies investigating complication rates of inva-
sive electrodes compare depth electrodes to subdural 
grids by reviewing cases in which both types of electrodes 
were implanted concurrently [2–6]. Placantonakis et al. 
[4] reported 26 patients where subdural strips were used, 
and depth electrodes placed in mesial lobes were added in 
50% of those patients. They noted no complications in-
volving the depth electrodes. Similarly, Hedegärd et al. [2] 
reported minor complications in 13 of 271 (4.8%) cases 
of invasive monitoring. However, this complication rate 
includes both grid and depth electrodes. Of their 14 depth 
electrode cases, 1 had a complication, resulting in a per-
case complication rate of 7.1%. In the present series we 
review a larger pool of procedures utilizing only depth 
electrodes. Thus, we present a more realistic evaluation of 
depth electrode risks and complications. 
Schmidt et al. [5] retrospectively reviewed 317 elec-
trode implantation procedures with a total of 768 depth 
electrodes and showed a case-based complication rate of 
25.5%. The majority of patients underwent 3 or 4 elec-
trode implants per patient, which makes it difficult to 
compare to our series (average 10 electrodes per patient) 
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or other SEEG studies with a higher number of implants. 
However, it is interesting to note that our case-base com-
plication rate is similar. This observation suggests that 
safety is not significantly compromised by adding more 
electrodes, although the limits of how many electrodes 
would significantly increase risk remains to be deter-
mined.
Our study reports complications not noted by others. 
For example, we include technical complications such as 
bolt or electrode insertion and/or removal difficulties, 
which were not considered in the previous studies. When 
removing this category from our analysis, we found a 
11.3% per-case and 1.1% per-electrode complication rate, 
which compares favorably to the existing studies that ex-
clude this criterion. Furthermore, a recent meta-analysis 
of depth electrode monitoring cases [3] found that in 
2,624 patients, the most common complication was hem-
orrhage followed by infection. However, we found our 
most common complication to be hardware malfunction 
or breakage involving an anchor bolt or an electrode dur-
ing insertion or removal procedures, which pose minimal 
threat to patients and are easily resolvable. We report no 
cases of infection. 
An important goal of this study was to demonstrate the 
safety of hybrid depth electrodes with associated microw-
ires during monitoring, which has not been previously 
documented for a subject pool of this size. Hefft et al. [19] 
reviewed 25 cases using both hybrid and standard depth 
electrodes and reported no clinically significant compli-
cations associated with hybrid depth electrodes. Likewise, 
when examining our cases, we were unable to conclude 
that hybrid depth electrodes (as compared to standard 
depth electrodes) had a direct causal association with the 
complications. 
Using hybrid depth electrodes allows investigators to 
simultaneously study single-neuron recordings and hu-
man behavior, providing novel information about the 
neurophysiological underpinnings of cognition [8, 19, 24, 
25]. In addition, some studies indicate that single-unit 
recordings may have clinical utility [26–30]. Such exam-
ples include using single-neuron activity to predict sei-
zure onset zones [26] and investigate the mechanisms 
underlying regional seizure spread [27], as well as char-
acterizing the functional connectivity in epileptic net-
works [28] and the neural oscillatory signatures of the 
epileptogenic brain [29]. Steinmetz et al. [30] used single-
neuron activity to measure the degree of functional con-
nection between neurons within epileptic hypothalamic 
hamartomas and identified different electrophysiological 
phenotypes. A complete data set of single-unit activity 
and behavioral data is available for download [31]. These 
studies only begin to reveal the significant clinical utility 
that hybrid depth electrodes might offer. 
Our results confirm the safety and utility of depth elec-
trodes for intracranial epilepsy monitoring. They also 
support the view that hybrid and non-hybrid depth elec-
trodes appear to be equally safe. Patients undergoing 
depth electrode monitoring have an increased likelihood 
of progressing to resective surgery and better outcome at 
1 year when compared to other intracranial monitoring 
methods [7]. In line with this report, we found that 61.5% 
of our patients were able to have their seizures fully local-
ized, with no difference in localization accuracy between 
hybrid and non-hybrid depth electrodes. These finding 
are likely reflective of the fact that patients with mesial 
temporal epilepsy are most likely to undergo depth elec-
trode monitoring and are also most likely to have success-
ful localization and surgical outcomes. They do not sug-
gest that depth electrodes are superior at localizing sei-
zures than subdural grids, which are more commonly 
used for neocortical epilepsy. Further experience with 
high-density SEEG will be needed to clarify that issue.
Conclusion
The localization accuracy and safety of hybrid elec-
trodes appear to be equal to those of non-hybrid elec-
trodes. Further, they provide a unique opportunity to 
investigate single-neuron activity during intracranial 
monitoring. 
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